Results 31 to 40 of about 10,487 (253)

Warty Carcinoma Penis: An Uncommon Variant

open access: yesCase Reports in Pathology, 2017
Penile carcinoma frequency varies widely in different parts of the world and comprises 1–10% of all the malignancies in males. Majority of the cases of penile carcinoma are squamous cell carcinoma of penis comprising 60% to 70% of all cases.
Sushma Thapa   +5 more
doaj   +1 more source

Prognostic Markers and Trials in Penile Cancer

open access: yesUrology Research and Practice, 2023
New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies.
Naufal Naushad   +4 more
doaj   +1 more source

Surgical Management of Penile and Preputial Neoplasms in Equine with Special Reference to Partial Phallectomy [PDF]

open access: yesJournal of Veterinary Medicine, 2013
Penile and preputial neoplasia in horses occurs infrequently and represents diagnostic and therapeutic challenges. The present study was carried out on a total number of 21 equids (14 stallions and 7 donkeys) suffered from different penile and preputial neoplasia.
Awad Rizk   +3 more
openaire   +2 more sources

Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999–2020 [PDF]

open access: yesInvestigative and Clinical Urology
Purpose: Cancer is a disease with high social costs, and policymaking through accurate statistics is very important. This study presents the national cancer statistics on the incidence of urological cancers in the Republic of Korea over 22 years, from ...
Seunghyeon Cho, Won-Ju Park
doaj   +1 more source

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Penile melanoma

open access: yesBrazilian Journal of Oncology, 2021
Penile melanoma is a rare event, responsible for less than 1.4% of penile cancers. In general, it is late diagnosed and the treatment is usually aggressive.
Luiz Felipe de Mello Pereira Leitão   +6 more
doaj   +1 more source

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

open access: yesMolecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico   +5 more
wiley   +1 more source

Deep Inguinal Lymph Node Metastases Can Predict Pelvic Lymph Node Metastases and Prognosis in Penile Squamous Cell Carcinoma

open access: yesFrontiers in Oncology, 2021
ObjectivesTo evaluate the relationship between deep inguinal lymph node metastasis (ILNM) and pelvic lymph node metastasis (PLNM) and explore the prognostic value of deep ILNM in penile squamous cell carcinoma (PSCC).Materials and MethodsThe records of ...
Zhenyu Yang   +35 more
doaj   +1 more source

Epidemiological Analysis of Penile Neoplasms in Brazil and Its Social Determinants

open access: yesInternational Journal of Social Science Studies, 2020
Introduction: Penile neoplasms, although preventable, are frequent even among young persons. Penile neoplasms have a high risk of not only morbidity and mortality but also important psychosocial repercussions.Objective: To describe the epidemiology of penile neoplasms in Brazil. Method: This was an epidemiological, descriptive and cross-sectional study.
Marcelo Cabral Lamy de Miranda   +6 more
openaire   +2 more sources

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH‐SY5Y and U‐87 MG cancer cells

open access: yesFEBS Open Bio, EarlyView.
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy